医学
替代医学
不利影响
重症监护医学
糖尿病
中医药
临床试验
传统医学
2型糖尿病
医疗保健
医疗保健系统
药理学
内科学
病理
内分泌学
经济
经济增长
出处
期刊:Current Diabetes Reviews
[Bentham Science]
日期:2018-10-10
卷期号:14 (6): 487-496
被引量:45
标识
DOI:10.2174/1573399813666170519103230
摘要
Background: Across the world, the economic and health costs of diabetes are rising at an alarming rate. Each year in the United States, billions of dollars are spent on T2 Diabetes mellitus (T2DM) treatments, but such treatments are not always effective and can lead to adverse events. Many pharmacological treatments exist to control the primary and secondary symptoms of T2DM, but these medications are not always efficacious, do little to treat secondary T2DM symptoms, and often carry adverse side effects. Traditional Chinese Medicine (TCM) is a form of alternative medicine that is becoming appealing to western healthcare systems because of its comprehensive, holistic approach to managing T2DM patients. Methods: Works across TCM printed texts, clinical trial databases, medical association practice guidelines, and the existing literature on TCM and western diabetes treatments (in print and online) are reviewed. Results: Conventional pharmaceutical therapies for T2DM are not efficacious enough to maintain satisfactory blood glucose levels for all patients, and even patients who maintain stable blood glucose levels may still suffer from secondary T2DM symptoms as well as from the side effects of their medications. TCM therapies have demonstrated promising results in T2DM clinical studies without causing the types of side effects associated with standard pharmaceutical treatments. In addition, the economic burden of TCM diabetes treatments on patients and payers is oftentimes less than that of pharmaceutical regimens. Conclusion: TCM approaches can be a viable alternative approach to treatment in the modern U.S. healthcare landscape, but a number of obstacles impede its assimilation into western health systems. Keywords: Diabetes, TCM, CAM, Chinese, acupuncture, herbal.
科研通智能强力驱动
Strongly Powered by AbleSci AI